Literature DB >> 16540952

Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.

Gladys Yumet1, Margaret L Shumate, D Patrick Bryant, Charles H Lang, Robert N Cooney.   

Abstract

OBJECTIVE: During sepsis, a two- to four-fold increase in circulating growth hormone (GH) is seen with 40-50% reductions in plasma insulin-like growth factor (IGF)-I. The suppressors of cytokine signaling (SOCS), inhibitors of cytokine, and growth factor signaling via the janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway have been implicated in the development of hepatic GH resistance. In this study we examine the effects of sepsis on GH-induced IGF-I expression and potential mechanisms for GH resistance.
DESIGN: Prospective experimental study.
SETTING: University research laboratory.
SUBJECTS: Male Sprague-Dawley rats.
INTERVENTIONS: Rats were randomized to laparotomy alone (control) or implantation of fecal agar pellets inoculated with Escherichia coli and Bacteroides fragilis (sepsis). GH was injected intravenously to assess hepatic IGF-I synthesis and GH signaling.
MEASUREMENTS AND MAIN RESULTS: Plasma IGF-I was measured in both groups at baseline (4 hrs postoperatively) and then again at 12 hrs and 24 hrs after GH administration. Basal IGF-I levels were similar in both groups, but controls had a 35% increase in IGF-I at 12 hrs, whereas septic rats demonstrated reductions in circulating IGF-I at 12 and 24 hrs after GH. Hepatic expression of SOCS-1, -2, -3, and cytokine-inducible SH2-containing protein (CIS) were determined at 1, 4, 8, and 24 hrs in septic and control rats by Northern blot. SOCS-1, SOCS-3, and CIS messenger RNA in liver were increased from 4 to 8 hrs after the induction of sepsis (p < .05 for SOCS-1 and -3). Total GH receptor (GHR), JAK2, and STAT5 signaling proteins and the time course of STAT5 activation were also measured in liver after recombinant human GH administration by immunoblot and electrophoretic mobility shift analysis. Levels of total GHR, JAK2, and STAT5 were unaltered in liver from septic rats. However, phosphorylated STAT5 and STAT5 DNA binding were significantly reduced 30 mins after GH administration in liver from septic rats.
CONCLUSIONS: Sepsis diminished STAT5 phosphorylation and activity in liver as well as plasma IGF-I following GH administration. Hepatic messenger RNA expression of SOCS-1, SOCS-3, and CIS was transiently increased during abdominal sepsis and temporally associated with the development of hepatic GH resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540952     DOI: 10.1097/01.CCM.0000215113.66070.E0

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  15 in total

1.  Genetic contribution of suppressor of cytokine signalling polymorphisms to the susceptibility to infection after traumatic injury.

Authors:  A Zhang; W Gu; H Lu; L Zeng; L Zhang; D Du; J Hao; D Wen; X Wang; J Jiang
Journal:  Clin Exp Immunol       Date:  2018-09-09       Impact factor: 4.330

2.  Hepatic growth hormone resistance after acute injury.

Authors:  Ryan M Corrick; Li Li; Stuart J Frank; Joseph L Messina
Journal:  Endocrinology       Date:  2013-02-15       Impact factor: 4.736

3.  Endotoxin-induced growth hormone resistance in skeletal muscle.

Authors:  Yu Chen; Sumita Sood; Vidya M R Krishnamurthy; Peter Rotwein; Ralph Rabkin
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

4.  Insulin Growth Factor-I in Protein-Energy Malnutrition during Rehabilitation in Two Nutritional Rehabilitation Centres in Burkina Faso.

Authors:  S Kouanda; B Doulougou; V De Coninck; L Habimana; B Sondo; R Tonglet; J M Ketelslegers; A Robert
Journal:  J Trop Med       Date:  2009-03-17

5.  Induction of suppressors of cytokine signaling by the trichothecene deoxynivalenol in the mouse.

Authors:  Chidozie J Amuzie; Junko Shinozuka; James J Pestka
Journal:  Toxicol Sci       Date:  2009-07-22       Impact factor: 4.849

Review 6.  Mechanisms of growth impairment in pediatric Crohn's disease.

Authors:  Thomas D Walters; Anne M Griffiths
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09       Impact factor: 46.802

Review 7.  Genomic dissection of the cytokine-controlled STAT5 signaling network in liver.

Authors:  Atsushi Hosui; Lothar Hennighausen
Journal:  Physiol Genomics       Date:  2008-05-06       Impact factor: 3.107

8.  Nuclear factor-kappaB mediates the inhibitory effects of tumor necrosis factor-alpha on growth hormone-inducible gene expression in liver.

Authors:  Mark D Buzzelli; Murali Nagarajan; John F Radtka; Margaret L Shumate; Maithili Navaratnarajah; Charles H Lang; Robert N Cooney
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

9.  Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.

Authors:  Prapai Dejkhamron; Jamuna Thimmarayappa; Kateryna Kotlyarevska; Jinhong Sun; Chunxia Lu; Erin L Bonkowski; Lee A Denson; Ram K Menon
Journal:  Mol Cell Endocrinol       Date:  2007-05-29       Impact factor: 4.102

Review 10.  Recent advances in growth hormone signaling.

Authors:  Nathan J Lanning; Christin Carter-Su
Journal:  Rev Endocr Metab Disord       Date:  2006-12       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.